Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition  Hellen Gelband, MHS, Rengaswamy Sankaranarayanan, MD, Cindy L Gauvreau, PhD, Prof Susan Horton, PhD, Benjamin O Anderson, MD, Freddie Bray, DPhil, James Cleary, MD, Anna J Dare, PhD, Lynette Denny, MD, Mary K Gospodarowicz, MD, Sumit Gupta, MD, Prof Scott C Howard, MD, David A Jaffray, PhD, Felicia Knaul, PhD, Carol Levin, PhD, Linda Rabeneck, MD, Preetha Rajaraman, PhD, Terrence Sullivan, PhD, Edward L Trimble, MD, Prof Prabhat Jha, DPhil  The Lancet  DOI: 10.1016/S0140-6736(15)00755-2 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Incidence and mortality of some cancer types in people aged younger than 70 years in low-income and middle-income countries in 2012 Data are from Ferlay and colleagues.13 The Lancet DOI: (10.1016/S0140-6736(15)00755-2) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Country income groupings in 2013 Data are based on World Bank income groupings. The Lancet DOI: (10.1016/S0140-6736(15)00755-2) Copyright © 2015 Elsevier Ltd Terms and Conditions